title: Efficacy of convective-controlled double high-flux hemodiafiltration versus on-line hemodiafiltration: 1-year prospective study.
abstract: BACKGROUND
  A recent cross-sectional study demonstrated that convective-controlled double high-flux hemodiafiltration (CC-HDF) could yield equivalent removal of small and middle molecule uremic toxins to on-line hemodiafiltration (OL-HDF).
  
  
  METHODS
  The present study was conducted to compare the 1-year efficacy between CC-HDF (n = 10) and OL-HDF (n = 16) in chronic hemodialysis patients undergoing thrice weekly high-flux hemodialysis for at least 6 months.
  
  
  RESULTS
  When compared with baseline (high-flux hemodialysis), 1-year treatment with both HDF modes had comparable efficacy in significantly lowering serum pre-dialysis beta(2)-microglobulin (beta(2)m) levels (p < 0.05) and significantly enhancing greater urea reduction ratio (p < 0.05). Both HDF modes could comparably maintain the hematology profile, calcium-phosphorus metabolism, and nutritional status according to the K-DOQI guidelines.
  
  
  CONCLUSIONS
  CC-HDF can provide equivalent 1-year efficacy to OL-HDF and would be an effective alternative mode to OL-HDF.
authors.affiliation: Extracorporeal Multiorgan Support Dialysis Excellent Center, Chulalongkorn University, Bangkok, Thailand.
authors.forename: Paweena
authors.initials: P
authors.lastname: Susantitaphong
authors.forename: Khajohn
authors.initials: K
authors.lastname: Tiranathanagul
authors.forename: Pisut
authors.initials: P
authors.lastname: Katavetin
authors.forename: Natavudh
authors.initials: N
authors.lastname: Townamchai
authors.forename: Kearkiat
authors.initials: K
authors.lastname: Praditpornsilpa
authors.forename: Kriang
authors.initials: K
authors.lastname: Tungsanga
authors.forename: Somchai
authors.initials: S
authors.lastname: Eiam-Ong
mesh_terms: D017583:Hemodiafiltration / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000401:mortality / Q000628:therapy; D009862:Online Systems / Q000295:instrumentation; D011446:Prospective Studies; D001613:beta 2-Microglobulin / Q000097:blood
chemical_list: D001613:beta 2-Microglobulin